<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dicerna Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The Company is using its proprietary GalXC RNAi technology platform to build a broad pipeline in these therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $188,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas M. Fambrough, III, Ph.D.
    • FOUNDED
      2007
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Acer Therapeutics Inc.

    Acer Therapeutics Inc.

    Acer is a pharmaceutical company focused on the acquisition, development and comme...

    Acer is a pharmaceutical company focused on the...

    Filing Type:    PU
    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology compa...

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a...

    Filing Type:    PU
    Cyclacel Pharmaceuticals, Inc.

    Cyclacel Pharmaceuticals, Inc.

    Cyclacel's founding scientist, Professor Sir David Lane, a globally recognized aut...

    Cyclacel's founding scientist, Professor Sir Da...

    Filing Type:    PU
    Roche Holding Ltd

    Roche Holding Ltd

    Together, a potent new drug and a blood test to guide its use can be a life change...

    Together, a potent new drug and a blood test to...

    Filing Type:    PU
    Exicure, Inc.

    Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of ...

    Exicure, Inc. is a clinical stage biotechnology...

    Filing Type:    PU
    OncoSec Medical Incorporated

    OncoSec Medical Incorporated

    OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on ...

    OncoSec Medical Incorporated is a clinical-stag...

    Filing Type:    PU
    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused o...

    Mirum Pharmaceuticals Inc. is a clinical-stage ...

    Filing Type:    PU
    Galmed Pharmaceuticals Ltd.

    Galmed Pharmaceuticals Ltd.

    Galmed is a clinical-stage biopharmaceutical company focused on the development of...

    Galmed is a clinical-stage biopharmaceutical co...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    iRhythm Technologies, Inc.

    iRhythm Technologies, Inc.

    iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are...

    iRhythm is a digital healthcare company redefin...

    Filing Type:    PU
    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device compan...

    Cardiovascular Systems, Inc., based in St. Paul...

    Filing Type:    PU
    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics™ designs, develops, manufactures, and markets proprietary...

    Hypertension Diagnostics™ designs, develops, ma...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.